Statistics
Publications
10
Citations
763
H-Index
10
Active since
2008
I. D. Stolyarov is an author at Institute of the Human Brain specializing in multiple sclerosis, multiple sclerosis therapy, and neurology.
Publications per year
2008–2018
10
10
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
Alasdair Coles, Edward Fox, Anton Vladić et al. · Neurology · 2012 · 267 citations
Long-term safety and efficacy of teriflunomide
Paul O’Connor, Mark S. Freedman, Aaron Miller et al. · Neurology · 2016 · 126 citations · Full text
Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
Jeremy Chataway, Keith F. Martin, Kevin Barrell et al. · Neurology · 2018 · 98 citations · Full text
Pharmacy, Neurology, Pharmacotherapy +15
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients
Gavin Giovannoni, Jeffrey Cohen, Alasdair Coles et al. · Neurology · 2016 · 62 citations · Full text
Medicine, Neurology, Pharmacotherapy +13
1–5 of 10